Increased Epoxyeicosatrienoic Acids and Reduced Soluble Epoxide Hydrolase Expression in the Preeclamptic Placenta

Overview

Journal J Hypertens

Specialty Cardiology & Vascular Diseases

Date 2016 Apr 27

PMID 27115337

Citations 13

Authors

Francesco Dalle Vedove

Cristiano Fava

Houli Jiang

Giovanni Zanconato

John Quilley

Matteo Brunelli

Valeria Guglielmi

Gaetano Vattemi

Pietro Minuz

Affiliations

Soon will be listed here.

Abstract

Background: Epoxyeicosatrienoic acids (EETs) derived from cytochrome P450 (CYP)-dependent metabolism of arachidonic acid are increased in the plasma of women with preeclampsia as compared with normal pregnancy and are significantly higher in fetal than in maternal plasma and erythrocytes. We hypothesized that differences in EET synthesis or metabolism in the feto-placental unit contributed to the observed differences in circulating EETs.

Method: To evaluate EETs, formation as well as the expression of relevant CYP isoforms and the metabolizing enzyme, soluble epoxide hydrolase (sEH), biopsies of placenta were collected from 19 normal pregnancy and 10 preeclampsia at the time of cesarean section delivery. EETs were extracted from tissue homogenates and analyzed by liquid chromatography coupled with tandem mass spectrometry.

Results: Both cis-EETs and trans-EETs were detected in the placenta. Concentration of total EETs was higher in the placenta from preeclampsia compared with normal pregnancy (2.37 ± 1.42 ng/mg vs. 1.20 ± 0.72 ng/mg, mean ± SD, P < 0.01), especially the 5,6-, 8,9- and 11,12-EETs, measured in a subgroup of tissue samples (normal pregnancy = 10, preeclampsia = 5). By immunohistochemistry, sEH, CYP2J2, CYP4A11 were present in placental villi with different pattern distribution, whereas CYP2C8 was not detectable. Neither were CYP2J2, CYP4A11, and CYP2C8 detected in the umbilical cord. Western blot analysis of placenta homogenates showed reduced expression of sEH in preeclampsia as compared with normal pregnancy.

Conclusion: Increased EETs in the placenta and umbilical cord are associated with the presence of CYP2J2, whereas reduced expression of sEH in preeclampsia may be the key factor of increased EETs in the placenta.

Citing Articles

Arachidonic acid-derived dihydroxy fatty acids in neonatal cord blood relate symptoms of autism spectrum disorders and social adaptive functioning: Hamamatsu Birth Cohort for Mothers and Children (HBC Study).

Hirai T, Umeda N, Harada T, Okumura A, Nakayasu C, Ohto-Nakanishi T Psychiatry Clin Neurosci. 2024; 78(9):546-557.

PMID: 39041066 PMC: 11488600. DOI: 10.1111/pcn.13710.

Cross-Sectional Associations between Prenatal Per- and Poly-Fluoroalkyl Substances and Bioactive Lipids in Three Environmental Influences on Child Health Outcomes (ECHO) Cohorts.

Suthar H, Manea T, Pak D, Woodbury M, Eick S, Cathey A Environ Sci Technol. 2024; 58(19):8264-8277.

PMID: 38691655 PMC: 11097396. DOI: 10.1021/acs.est.4c00094.

Frequency of Gene Polymorphisms in Admixed Venezuelan Women with Recurrent Pregnancy Loss: Microsomal Epoxy Hydroxylase (rs1051740) and Enos (rs1799983).

Pena M, De Sanctis C, De Sanctis J, Garmendia J Curr Issues Mol Biol. 2024; 46(4):3460-3469.

PMID: 38666947 PMC: 11049659. DOI: 10.3390/cimb46040217.

Cross-sectional associations between prenatal maternal per- and poly-fluoroalkyl substances and bioactive lipids in three Environmental influences on Child Health Outcomes (ECHO) cohorts.

Suthar H, Manea T, Pak D, Woodbury M, Eick S, Cathey A medRxiv. 2023; .

PMID: 37961525 PMC: 10635258. DOI: 10.1101/2023.11.03.23297930.

Associations of phthalates, phthalate replacements, and their mixtures with eicosanoid biomarkers during pregnancy.

Park S, Cathey A, Hao W, Zeng L, Pennathur S, Aung M Environ Int. 2023; 178:108101.

PMID: 37487376 PMC: 10733973. DOI: 10.1016/j.envint.2023.108101.

References

Fleming I . The pharmacology of the cytochrome P450 epoxygenase/soluble epoxide hydrolase axis in the vasculature and cardiovascular disease. Pharmacol Rev. 2014; 66(4):1106-40. DOI: 10.1124/pr.113.007781. View

Patel L, Sullivan M, Elder M . Production of epoxygenase metabolite by human reproductive tissues. Prostaglandins. 1989; 38(6):615-24. DOI: 10.1016/0090-6980(89)90044-0. View

Zhang J, Pearson T, Matharoo-Ball B, Ortori C, Warren A, Khan R . Quantitative profiling of epoxyeicosatrienoic, hydroxyeicosatetraenoic, and dihydroxyeicosatetraenoic acids in human intrauterine tissues using liquid chromatography/electrospray ionization tandem mass spectrometry. Anal Biochem. 2007; 365(1):40-51. DOI: 10.1016/j.ab.2007.03.001. View

Wilhelm M, Schlegl J, Hahne H, Gholami A, Lieberenz M, Savitski M . Mass-spectrometry-based draft of the human proteome. Nature. 2014; 509(7502):582-7. DOI: 10.1038/nature13319. View

Schafer W, Zahradnik H, Arbogast E, Wetzka B, Werner K, Breckwoldt M . Arachidonate metabolism in human placenta, fetal membranes, decidua and myometrium: lipoxygenase and cytochrome P450 metabolites as main products in HPLC profiles. Placenta. 1996; 17(4):231-8. DOI: 10.1016/s0143-4004(96)90043-0. View

Schafer W, Werner K, Schweer H, Schneider J, Zahradnik H . Formation of cytochrome P450 metabolites of arachidonic acid by human placenta. Adv Exp Med Biol. 1997; 433:411-3. DOI: 10.1007/978-1-4899-1810-9_90. View

Young B, Levine R, Karumanchi S . Pathogenesis of preeclampsia. Annu Rev Pathol. 2010; 5:173-92. DOI: 10.1146/annurev-pathol-121808-102149. View

Wu C, Orozco C, Boyer J, Leglise M, Goodale J, Batalov S . BioGPS: an extensible and customizable portal for querying and organizing gene annotation resources. Genome Biol. 2009; 10(11):R130. PMC: 3091323. DOI: 10.1186/gb-2009-10-11-r130. View

Luksha L, Nisell H, Luksha N, Kublickas M, Hultenby K, Kublickiene K . Endothelium-derived hyperpolarizing factor in preeclampsia: heterogeneous contribution, mechanisms, and morphological prerequisites. Am J Physiol Regul Integr Comp Physiol. 2007; 294(2):R510-9. DOI: 10.1152/ajpregu.00458.2007. View

10.

Oguro A, Sakamoto K, Suzuki S, Imaoka S . Contribution of hydrolase and phosphatase domains in soluble epoxide hydrolase to vascular endothelial growth factor expression and cell growth. Biol Pharm Bull. 2009; 32(12):1962-7. DOI: 10.1248/bpb.32.1962. View

11.

Herse F, LaMarca B, Hubel C, Kaartokallio T, Lokki A, Ekholm E . Cytochrome P450 subfamily 2J polypeptide 2 expression and circulating epoxyeicosatrienoic metabolites in preeclampsia. Circulation. 2012; 126(25):2990-9. PMC: 3543781. DOI: 10.1161/CIRCULATIONAHA.112.127340. View

12.

Minuz P, Jiang H, Fava C, Turolo L, Tacconelli S, Ricci M . Altered release of cytochrome p450 metabolites of arachidonic acid in renovascular disease. Hypertension. 2008; 51(5):1379-85. PMC: 4544761. DOI: 10.1161/HYPERTENSIONAHA.107.105395. View

13.

Jiang H, McGiff J, Fava C, Amen G, Nesta E, Zanconato G . Maternal and fetal epoxyeicosatrienoic acids in normotensive and preeclamptic pregnancies. Am J Hypertens. 2013; 26(2):271-8. PMC: 3935001. DOI: 10.1093/ajh/hps011. View

14.

Li L, Li N, Pang W, Zhang X, Hammock B, Ai D . Opposite effects of gene deficiency and pharmacological inhibition of soluble epoxide hydrolase on cardiac fibrosis. PLoS One. 2014; 9(4):e94092. PMC: 3981766. DOI: 10.1371/journal.pone.0094092. View

15.

Ai D, Fu Y, Guo D, Tanaka H, Wang N, Tang C . Angiotensin II up-regulates soluble epoxide hydrolase in vascular endothelium in vitro and in vivo. Proc Natl Acad Sci U S A. 2007; 104(21):9018-23. PMC: 1885620. DOI: 10.1073/pnas.0703229104. View

16.

El-Sherbeni A, El-Kadi A . The role of epoxide hydrolases in health and disease. Arch Toxicol. 2014; 88(11):2013-32. DOI: 10.1007/s00204-014-1371-y. View

17.

Enayetallah A, French R, Grant D . Distribution of soluble epoxide hydrolase, cytochrome P450 2C8, 2C9 and 2J2 in human malignant neoplasms. J Mol Histol. 2006; 37(3-4):133-41. DOI: 10.1007/s10735-006-9050-9. View

18.

Fan F, Muroya Y, Roman R . Cytochrome P450 eicosanoids in hypertension and renal disease. Curr Opin Nephrol Hypertens. 2014; 24(1):37-46. PMC: 4260681. DOI: 10.1097/MNH.0000000000000088. View

19.

Keseru B, Barbosa-Sicard E, Schermuly R, Tanaka H, Hammock B, Weissmann N . Hypoxia-induced pulmonary hypertension: comparison of soluble epoxide hydrolase deletion vs. inhibition. Cardiovasc Res. 2009; 85(1):232-40. PMC: 2860707. DOI: 10.1093/cvr/cvp281. View

20.

Michaelis U, Fisslthaler B, Barbosa-Sicard E, Falck J, Fleming I, Busse R . Cytochrome P450 epoxygenases 2C8 and 2C9 are implicated in hypoxia-induced endothelial cell migration and angiogenesis. J Cell Sci. 2005; 118(Pt 23):5489-98. DOI: 10.1242/jcs.02674. View